MedTrace Logo

Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer

NCT02524808 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2015-08-17

No results posted yet for this study

Summary

This is an observational prospective study. Patients diagnosed with advanced epithelial ovarian cancer (stage IC or higher) since 2008 will be asked to participate in this study by signing an informed consent. Tumour samples will be reviewed to confirm the diagnosis and to select the best regions for tissue sampling to perform the following molecular studies: array-based Comparative Genomic Hybridization and Next Generation Sequencing. Detected mutations will be analysed by Sanger sequencing. FISH probes will be designed and tested on the samples.

Conditions

  • Ovarian Neoplasms

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Fundación de investigación HM

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2015-12-31
Completion
2016-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02524808 on ClinicalTrials.gov